SB

Scott Barclay

Managing Director, Healthcare, Insight Partners

Palo Alto, California

Invests in

  • Min Investment:

    $10,000,000.00
  • Max Investment:

    $350,000,000.00
  • Target Investment:

    $25,000,000.00

Education

Work Experience

  • Managing Director, Healthcare

    2021

    Investing in and serving founders rebuilding healthcare, now as part of the world's best venture capital culture that is Insight Partners. Every stage, every time zone.

Clay VC

2021 - 2022

  • Founder and GP, Clay VC

    2021 - 2022

    Clay VC is a new early-stage investing firm rebuilding the future of healthcare by finding and serving founders at the intersection of deep tech, data, and empathy. We call this next era Computational Care. Based in Palo Alto, CA and serving founders globally. (This description is not a solicitation for investment or investment advice)

2020 - 2021

  • Partner

    2020 - 2021

    Building a special purpose diverse team to invest in and serve founders who themselves are technical, ambitious, and building the future of healthcare in the US and globally

2020 - 2020

  • Investor

    2020 - 2020

    Jumped in to help catalyze & fund Fred Turner and a wonderful team to rapidly build a COVID19 Diagnostic oral-liquid diagnostic test

2019 - 2020

  • Board Observer

    2019 - 2020

    Next-generation blood tests for early cancer detection powered by a machine-driven, multiomics platform. DCVC investor since 2015; Board Observer since July 2019

2019 - 2020

  • Board Director

    2019 - 2020

    Building the future of urgent care

2018 - 2020

  • Investor

    2018 - 2020

    FDA compliance and submission offered as a machine-driven SaaS service

2018 - 2020

  • Board Observer

    2018 - 2020

    "We build machines that read and write"

2018 - 2020

  • Board Director

    2018 - 2020

    Computer vision at the bedside, on the smartphone, solving wound care

2017 - 2020

  • Investor

    2017 - 2020

    Deep leaning to drastically improve imaging infrastructure, in PET and MR